Senior Research Associate and Lecturer
The Heller School for Social Policy and Management
Health Economics, Public Policy Analysis, Health Policy, Cost-Effectiveness Analysis, Health Financing Reform, Health Insurance, Health Services Research, Evaluation Research, Quantitative Research, Applications of Information Technology (IT) in Health Policy and Health Services Research
Moaven Razavi, PhD is a Senior Research Associate in the Schneider Institutes for Health Policy at the Heller School of Brandeis University.
From 1997-2005, he held a faculty appointment in the Institute for Research in Planning and Development (IRPD) in Tehran, Iran. He was appointed Director of the Bureau for Development Research of the Institute from 2003 to 2005. He has served as a member of Iran’s National Committee of Health Sector Reform since 2002. From 1999 to 2003, he served as a senior co-investigator of the Good Governance Project: National Budgeting Reform, a project sponsored by the United Nations Development Programme (UNDP). Dr. Razavi also led the preparation of The First Millennium Development Goals (MDG) Report 2004: Achievements and Challenges as the lead author and the member of editorial committee.
Dr. Razavi’s key contributions to health policy owe to his leadership in conducting a series of studies funded by The World Bank and the World Health Organization on the subject of poverty and health with a focus on catastrophic health expenditures. In October 2002, he represented Iran’s health sector in a global conference on Poverty and Health held by the World Health Organization and Harvard University in Greece.
In 2005, Dr. Razavi was awarded an International Ford Foundation Fellowship in International Health Policy at Brandeis University, and one year later he was awarded the Heller School Scholarship for the PhD program in Health Policy. He officially joint the the Schneider Institutes for Health Policy in 2008. At the Schneider Institutes, he worked with the Institute for Global Health and Development as well as the Institutes on Health Care Systems and co-authored numerous working papers supported by the Bill and Melinda Gates Foundation, The World Bank, and the US federal agencies. He was a co-recipient of the Massachusetts General Hospital’s Clinical Innovation Award (2008) and presented his research to the Massachusetts Medical Society in competition for the MMS Information Technology Award 2009.
Dr. Razavi has published extensively on topics in social and health policy and has recently co-authored publications in US peer-reviewed journals. He has co-authored reports based on his evaluation research for the Centers for Medicaid and Medicare (CMS).
He is currently the task lead for Identification of Inefficiencies in Health Care Spending for State of Vermont and served as project manager of the Medicare Health Plan Value Methodology, and a senior researcher in other health policy research projects including membership in the Technical Assistance Team to the Beacon Community Medicare Claims Data Performance Measurement project for CMS. The project Episode Grouper for Medicare is another federally funded project in which Dr. Razavi is serving as a Senior Research Associate. His particular contribution is in development of software applications needed for building and analyzing the Episodes.
Dr. Razavi has received research support from diverse institutions such as The World Bank, World Health Organization, UNDP, the Bill and Melinda Gates Foundation, GSK pharmaceutical Co., State of Vermont, and the Center for Medicare and Medicaid (CMS). He teaches various subjects in health policy and health economics at graduate level.
Brandeis University, Ph.D.
Brandeis University, M.S.
Institute for Management and Planning Studies, M.S.
Khajeh Nasir Toosi University of Technology, B.S.
Awards and Honors
Ford Foundation Scholarship for Brandeis University. (2005)
|HS||266f||Introduction to Economics for Development Practitioners|
|HS||330f||International Health Economics|
|HS||340f||Advanced International Health Economics|
|HS||349f||Introduction to Health Economics|